Scientists identify 'missing link' in process leading to Alzheimer's disease

Scientists at the University of Virginia have identified what appears to be a major missing link in the process that destroys nerve cells in Alzheimer's disease, an incurable disease that slowly destroys memory and cognitive abilities. The findings are reported in the Nov. 20, 2006, issue of the Journal of Cell Biology and could eventually lead to new drugs that target and disrupt specific proteins that conspire in the brain to cause Alzheimer's.

In Alzheimer's disease, two kinds of abnormal structures accumulate in the brain: amyloid plaques and neurofibrillary tangles. The plaques contain fibrils that are made from protein fragments called "beta-amyloid peptides." The tangles also are fibrous, but they are made from a different substance, a protein called "tau." In the new U.Va. study, the researchers found a deadly connection between beta-amyloid and tau, one that occurs before they form plaques and tangles, respectively.

According to George Bloom, the senior author of the study and a professor of biology and cell biology at U.Va., this connection causes the swiftest, most sensitive and most dramatic toxic effect of beta-amyloid found so far. What makes it most remarkable, though, is that it requires a form of amyloid that represents the building blocks of plaques, so called "pre-fibrillar beta-amyloid," and it only happens in cells that contain tau. Even though they account for just ~10 percent of the cells in the brain, nerve cells are the major source of tau, which likely explains why they are specifically attacked in Alzheimer's disease.

The researchers used cultured mammalian cells that either did or did not make tau to study how cells respond to beta-amyloid. They found that pre-fibrillar, but not fibrillar beta-amyloid works together with tau to break apart microtubules — highways along which "synapse" replacement parts move rapidly in the nerve cell from where they are made to where they are needed. Synapses are connections between nerve cells, and in the brain they are the structural basis of memory and cognition. When nerve cells in the brain lose their microtubules they also lose the ability to replace worn out synapse parts, and synapses therefore disappear. The loss of synapses, and consequent loss of memories and cognitive skills, cannot be reversed, and can lead directly to nerve cell death.

"We think we've found one of the seminal cell biological events in the pathogenesis of Alzheimer's and if we can figure out all of the steps in the process and understand each player at every step, it will represent many potential new drug targets for Alzheimer's therapy," Bloom said. "Our paper defines one of the earliest events that causes neurons to die in both early-onset familial Alzheimer's and late-onset Alzheimer's disease. We believe this is the first evidence for the long elusive ‘missing link' between amyloid and tau in Alzheimer's disease."

"This is a very significant finding that greatly improves our understanding of the mechanisms within the cell that ultimately lead to Alzheimer's disease," said Lester Binder, professor of cell and molecular biology at Northwestern University and a leading researcher on Alzheimer's. Binder said he has already incorporated the U.Va. study into classes he teaches on the pathogenesis of Alzheimer's disease and dementia.

Reference: http://www.jcb.org/cgi/content/full/175/4/541

Source: University of Virginia

Related stories:

New study finds healthy children of Alzheimer patients show early brain changes
Medical College of Wisconsin researchers in Milwaukee have reported that children of Alzheimer's patients who are carriers of a genetic risk factor for Alzheimer's disease have neurological changes that are detectable long before clinical symptoms may appear.
Scientists demonstrate means of reducing Alzheimer's-like plaques in fly brain
Neuroscientists at Cold Spring Harbor Laboratory (CSHL) are part of a collaboration that has succeeded in demonstrating that overexpression of an enzyme in the brain can reduce telltale deposits causally linked with Alzheimer's disease.
Do mammals think in 3-D?
A team of neuroscientists at University College London (UCL) has begun to discover how the brain maps three-dimensional space. The work could one day aid in the understanding and treatment of Alzheimer’s disease, which involves the same area of the brain as encodes space.
Glia guide brain development in worms
Again and again, experiments confirmed it. Without glia, neurons die. So scientists who wanted to study in living animals what glia — the most abundant brain cells — do for neurons besides keep them alive were out of luck. But now, a breakthrough.
Study identifies toxic key to Alzheimer’s disease memory loss
Using new scientific techniques, scientists have unlocked the cascade of molecular events that lead to Alzheimer’s disease. The scientific findings published in the latest edition of Nature Medicine suggest a potential new target for the development of drug therapies to fight the irreversible and degenerative disease which affects some 29.8 million people worldwide. The total worldwide societal cost of dementia was estimated at somewhere in the region of US$315.4 billion in 2005.

Memory loss linked to common sleep disorder
For the first time, UCLA researchers have discovered that people with sleep apnea show tissue loss in brain regions that help store memory. Reported in the June 27 edition of the journal Neuroscience Letters, the findings emphasize the importance of early detection of the disorder, which afflicts an estimated 20 million Americans.
How to construct a 'firefly' worm
Research describing a new modified luminescent worm that allows, for the first time, to measure, in real time, the metabolism of an entire living organism has just been published in the journal BMC Physiology.
Researchers clear up Alzheimer's plaques in mice
Blocking a common immune system response cleared up plaques associated with Alzheimer’s Disease and enabled treated mice to recover some lost memory, Yale University researchers report Friday in the journal Nature Medicine.

News discussion:

Medicine & Health news